PACB — PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
—
Nasdaq ·
Unknown ·
Unknown ·
CIK 1299130 ·
Last close
$1.82
Market Cap
$565.71M
52W High
$3.44
52W Low
$1.07
ADV30
13,023,521
Next earnings
2026-11-04
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 40,564,000 | 13,470,000 | -37,002,000 | -37,846,000 | 721,096,000 | 55,907,000 | 782,476,000 |
| Jun 2026 | 39,007,000 | 12,638,000 | -44,610,000 | -44,741,000 | 751,850,000 | 61,003,000 | 785,063,000 |
| Mar 2026 | 37,178,000 | 12,841,000 | -54,153,000 | -8,275,000 | 782,365,000 | 56,274,000 | 779,999,000 |
| Dec 2025 | 44,645,000 | 16,566,000 | -41,197,000 | -40,371,000 | 784,083,000 | 63,707,000 | 778,734,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-118,050,000
Investing CF
$120,861,000
Financing CF
$3,161,000
CapEx
$-13,065,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.43
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$-2,748,318,000
Inventory
$61,084,000
Receivables
$31,104,000
ST Investments
$175,870,000
EBIT TTM
$-123,231,000
Pretax Income TTM
$-130,560,000
Interest Exp TTM
$7,329,000
Analysts
7
Yahoo Snapshot (yfinance, live)
Total Revenue
$161,394,000
EBITDA
$-153,032,992
Free Cash Flow
$291,644,736
Enterprise Value
$1,207,812,992
Total Cash
$199,418,000
Total Debt
$705,369,024
Shares Out
310,830,759
Trailing EPS
$-0.42
Book Value
$-0.20
ROE
-929.3%
ROA
-43.5%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 160,005,000 | -557,561,000 | -546,376,000 | 784,083,000 | 778,734,000 | 5,349,000 | -111,209,000 |
| Dec 2024 | 154,014,000 | -290,663,000 | -309,851,000 | 1,260,447,000 | 753,853,000 | 506,594,000 | -206,058,000 |
| Dec 2023 | 200,521,000 | -310,365,000 | -306,735,000 | 1,746,013,000 | 1,044,709,000 | 701,304,000 | -259,173,000 |
| Dec 2022 | 128,304,000 | -304,819,000 | -314,248,000 | 1,767,086,000 | 1,204,182,000 | 562,904,000 | -263,211,000 |
TTM Snapshot
Revenues TTM
$159,271,000
NetIncome TTM
$-131,387,000
OpCashFlow TTM
—
Assets (Latest)
$751,850,000
Forward EPS
$-0.42
Max Pain — expiry 2026-12-18
max pain strike: $2.00 · spot: $1.83 · call oi: 129,619 · put oi: 4,740
Expected Move to 2026-12-18:
±$0.38
(20.49%) —
implied range
$1.46 –
$2.21
· ATM straddle on $2.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| NCDL | Nuveen Churchill Direct Lending Corp. | $563.77M | $11.48 | — |
| SENS | Senseonics Holdings, Inc. | $556.57M | $10.16 | — |
| SBOEF | SBO AG/ADR | $555.52M | $35.25 | — |
| YSS | York Space Systems Inc. | $576.17M | $4.25 | — |
| VMO | Invesco Municipal Opportunity Trust | $577.29M | $8.56 | — |
News headlines (Yahoo Finance, 1h cache)
PacBio to Participate in the Piper Sandler 38th Annual Healthcare Conference
2026-11-17 21:05 · Yahoo
Here's Why Pacific Biosciences (PACB) Is a Great 'Buy the Bottom' Stock Now
2026-11-16 13:55 · Yahoo
PacBio (PACB) Stock Sees Split Analyst Revisions As Fair Value Edges Higher
2026-11-16 05:14 · Yahoo
Pacific Biosciences of California Inc (PACB) (Q3 2026) Earnings Call Highlights: Revenue Grows ...
2026-11-05 21:08 · Yahoo
Pacific Biosciences of California (PACB) Reports Q3 Loss, Beats Revenue Estimates
2026-11-04 23:45 · Yahoo
What Pacific Biosciences of California (PACB) Said on Its Q3 Earnings Call
2026-11-04 23:14 · Yahoo
Pacific Biosciences: Q3 Earnings Snapshot
2026-11-04 22:24 · Yahoo
PacBio (NASDAQ:PACB) reports bullish Q3 2026
2026-11-04 21:45 · Yahoo
PacBio Announces Third Quarter 2026 Financial Results
2026-11-04 21:05 · Yahoo
Pacific Biosciences of California (PACB) Rises As Market Takes a Dip: Key Facts
2026-10-29 21:15 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.